Related Experiment Video
Updated: May 28, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation
Sonia Khiljee1, Mahmood Ahmad, Ghulam Murtaza
1Department of Pharmacy, Faculty of Pharmacy and Alternative Medicines,The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.
Abstract:
Present study was designed to establish in-vitro and in-vivo correlation (IVIVC) of two immediate release tablet formulations of 400mg Norfloxacin [Drug A as test and Drug B as reference]. Dissolution study was conducted in 0.1 N HCl using USP apparatus II. In-vivo evaluation was carried out in 18 healthy humans according to a single dose, two-sequence, and cross-over randomized with a wash-out period of one week. After dosing, serial blood samples were collected for a period of 10 hours. Plasma harvested from blood, was analyzed for norfloxacin by a sensitive, reproducible and accurate HPLC method. Various pharmacokinetic parameters were determined from plasma concentrations for both the formulations. Non-significant difference was found for test/reference ratio of these parameters and the value of F was found to be 0.99 which is in good agreement with the limits given in FDA and WHO guidelines for such parameters. Difference factor (f(1)), similarity factor (f(2)) and level A IVIVC were evaluated showing that drug A is bioequivalent to drug B.
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
Bioequivalence studies: Biowaivers
Equivalence: In Vitro and In Vivo Bioequivalence
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Bioequivalence: Overview
In Vitro Drug Dissolution: Compendial Testing Models II
